MicroRNA expression in the cervix during pregnancy is associated with length of gestation

Epigenetics

Volumn 10, Issue 3, 2015, Pages 221-228

  Sanders, Alison P ^a   Burris, Heather H ^b   Just, Allan C ^c   Motta, Valeria ^c,d   Svensson, Katherine ^a   Mercado Garcia, Adriana ^e   Pantic, Ivan ^c,f   Schwartz, Joel ^c   Tellez Rojo, Martha M ^e   Wright, Robert O ^a   Baccarelli, Andrea A ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^e INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^f INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

Author keywords

Cervix; Delivery; Gestational age; Labor; MicroRNA; Pap smear; Preterm

Indexed keywords

MICRORNA; MICRORNA 142; MICRORNA 148B; MICRORNA 21; MICRORNA 223; MICRORNA 29B; MICRORNA 30E; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; DISEASE ASSOCIATION; DNA REPLICATION; FEMALE; GENE; GENE EXPRESSION; GESTATION PERIOD; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; INFLAMMATION; MATERNAL AGE; PAPANICOLAOU TEST; PARITY; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PROSPECTIVE STUDY; RISK FACTOR; RNA EXTRACTION; SMOKING; UTERINE CERVIX; ADOLESCENT; GENETICS; METABOLISM; PREMATURITY; YOUNG ADULT;

ADOLESCENT; ADULT; CERVIX UTERI; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; MICRORNAS; PREGNANCY; PREMATURE BIRTH; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84925294104     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.1080/15592294.2015.1006498     Document Type: Article

References (42)

1. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, Adler A, Vera Garcia C, Rohde S, Say L, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012; 379:2162-72; PMID:22682464; http://dx.doi.org/10.1016/S0140-6736(12)60820-4.
2. Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH, Rubens C, Menon R, Van Look PF. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 2010; 88:31-8; PMID:20428351; http://dx.doi.org/10.2471/BLT.08.062554.
3. IOM. In: Behrman RE, Butler AS, eds. Preterm Birth: Causes, Consequences, and Prevention. Washington (DC), 2007; http://www.ncbi.nlm.nih.gov/pubmed/20669423.
4. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008; 371:75-84; PMID:18177778; http://dx.doi.org/10.1016/S0140-6736(08)60074-4.
5. Trivedi S, Joachim M, McElrath T, Kliman HJ, Allred EN, Fichorova RN, Onderdonk A, Heitor F, Chaychi L, Leviton A, et al. Fetal-placental inflammation, but not adrenal activation, is associated with extreme preterm delivery. Am J Obstet Gynecol 2012; 206:236 e1-8; PMID:22264652; http://dx.doi.org/10.1016/j.ajog.2011.12.004.
6. Hecht JL, Fichorova RN, Tang VF, Allred EN, McElrath TF, Leviton A. Relationship Between Neonatal Blood Protein Concentrations and Placenta Histologic Characteristics in Extremely Low GA Newborns. Pediatr Res 2011; 69:68-73; PMID:20921924; http://dx.doi.org/10.1203/PDR.0b013e3181fed334.
7. Bakulski KM, Fallin MD. Epigenetic epidemiology: promises for public health research. Environ Mol Mutagen 2014; 55:171-83; PMID:24449392; http://dx.doi.org/10.1002/em.21850.
8. Freedman JE, Tanriverdi K. Defining miRNA targets: balancing simplicity with complexity. Circulation 2013; 127:2075-7; PMID:23625958; http://dx.doi.org/10.1161/CIRCULATIONAHA.113.003058.
9. Collignon J. miRNA in embryonic development: the taming of Nodal signaling. Dev Cell 2007; 13:458-60; PMID:17925220; http://dx.doi.org/10.1016/j.devcel.2007.09.012.
10. Lodish HF, Zhou B, Liu G, Chen CZ. Micromanagement of the immune system by microRNAs. Nat Rev Immunol 2008; 8:120-30; PMID:18204468; http://dx.doi.org/10.1038/nri2252.
11. Renthal NE, Chen CC, Williams KC, Gerard RD, Prange-Kiel J, Mendelson CR. miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc Natl Acad Sci U S A 2010; 107:20828-33; PMID:21079000; http://dx.doi.org/10.1073/pnas.1008301107.
12. Elovitz MA, Brown AG, Anton L, Gilstrop M, Heiser L, Bastek J. Distinct cervical microRNA profiles are present in women destined to have a preterm birth. Am J Obstet Gynecol 2014; 210:221 e1-11; PMID:24565431.
13. Hassan SS, Romero R, Pineles B, Tarca AL, Montenegro D, Erez O, Mittal P, Kusanovic JP, Mazaki-Tovi S, Espinoza J, et al. MicroRNA expression profiling of the human uterine cervix after term labor and delivery. Am J Obstet Gynecol 2010; 202:80 e1-8; PMID:AMBIGUOUS; http://dx.doi.org/10.1016/j.ajog.2009.08.016.
14. Buscaglia LE, Li Y. Apoptosis and the target genes of microRNA-21. Chin J Cancer 2011; 30:371-80; PMID:21627859; http://dx.doi.org/10.5732/cjc.011.10132.
15. Kriegel AJ, Liu Y, Fang Y, Ding X, Liang M. The miR- 29 family: genomics, cell biology, and relevance to renal and cardiovascular injury. Physiol Genomics 2012; 44:237-44; PMID:22214600; http://dx.doi.org/10.1152/physiolgenomics.00141.2011.
16. Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, Sharp PA, Manjunath N. miRNA profiling of naive, effector and memory CD8 T cells. PloS One 2007; 2: e1020; PMID:17925868; http://dx.doi.org/10.1371/journal.pone.0001020.
17. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007; 449:919-22; PMID:17943132; http://dx.doi.org/10.1038/nature06205.
18. Ruan Q, Wang P, Wang T, Qi J, Wei M, Wang S, Fan T, Johnson D, Wan X, Shi W, et al. MicroRNA-21 regulates T-cell apoptosis by directly targeting the tumor suppressor gene Tipe2. Cell Death Dis 2014; 5: e1095; PMID:24577093; http://dx.doi.org/10.1038/cddis.2014.47.
19. O’connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10:111-22; PMID:20098459; http://dx.doi.org/10.1038/nri2708.
20. Liu X, Zhan Z, Xu L, Ma F, Li D, Guo Z, Li N, Cao X. MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIalpha. J Immunol 2010; 185:7244-51; PMID:21068402; http://dx.doi.org/10.4049/jimmunol.1001573.
21. Gomez-Lopez N, StLouis D, Lehr MA, Sanchez-Rodriguez EN, Arenas-Hernandez M. Immune cells in term and preterm labor. Cell Mol Immunol 2014; 11 (6):571-81; PMID:24954221.
22. Romero R, Mazor M, Sepulveda W, Avila C, Copeland D, Williams J. Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol 1992; 166:1576-87; PMID:1595815; http://dx.doi.org/10.1016/0002-9378(92)91636-O.
23. Skarn M, Baroy T, Stratford EW, Myklebost O. Epigenetic regulation and functional characterization of microRNA-142 in mesenchymal cells. PloS one 2013; 8:e79231; PMID:24236112; http://dx.doi.org/10.1371/journal.pone.0079231.
24. Morita S, Horii T, Kimura M, Ochiya T, Tajima S, Hatada I. miR-29 represses the activities of DNA methyltransferases and DNA demethylases. Int J Mol Sci 2013; 14:14647-58; PMID:23857059; http://dx.doi.org/10.3390/ijms140714647.
25. Duursma AM, Kedde M, Schrier M, le Sage C, Agami R. miR-148 targets human DNMT3b protein coding region. RNA 2008; 14:872-7; PMID:18367714; http://dx.doi.org/10.1261/rna.972008.
26. Burris HH, Baccarelli AA, Motta V, Byun HM, Just AC, Mercado-Garcia A, Schwartz J, Svensson K, T_ellez-Rojo MM, Wright RO, et al. Association between length of gestation and cervical DNA methylation of PTGER2 and LINE 1-HS. Epigenetics 2014; 9:1083-91; PMID:24827772; http://dx.doi.org/10.4161/epi.29170.
27. Blake RL, Jr., Gay JW, Brown S, Smith W. Does evidence of inflammation on Papanicolaou smears of pregnant women predict preterm labor and delivery? J Am Board Fam Pract 1992; 5:555-63; PMID:1462789.
28. McDonald JA, Mojarro O, Sutton PD, Ventura SJ. A binational overview of reproductive health outcomes among US Hispanic and Mexican women in the border region. Prev Chronic Dis 2013; 10:E137; PMID:23948338; http://dx.doi.org/10.5888/pcd10.130019.
29. Alexander GR, Tompkins ME, Petersen DJ, Hulsey TC, Mor J. Discordance between LMP-based and clinically estimated gestational age: implications for research, programs, and policy. Public Health Rep 1995; 110:395-402; PMID:7638326.
30. Hall MH, Carr-Hill RA, Fraser C, Campbell D, Samphier ML. The extent and antecedents of uncertain gestation. Br J Obstet Gynaecol 1985; 92:445-51; PMID:3994927; http://dx.doi.org/10.1111/j.1471-0528.1985.tb01347.x.
31. Mestdagh P, Hartmann N, Baeriswyl L, Andreasen D, Bernard N, Chen C, Cheo D, D’andrade P, DeMayo M, Dennis L, et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat methods 2014; 11:809-15; PMID:24973947; http://dx.doi.org/10.1038/nmeth.3014.
32. Knutsen E, Fiskaa T, Ursvik A, Jorgensen TE, Perander M, Lund E, Seternes OM, Johansen SD, Andreassen M. Performance comparison of digital microRNA profiling technologies applied on human breast cancer cell lines. PloS one 2013; 8:e75813; PMID:24116077; http://dx.doi.org/10.1371/journal.pone.0075813.
33. Practice bulletin no. 130: prediction and prevention of preterm birth. Obstet Gynecol 2012; 120:964-73; PMID:22996126; http://dx.doi.org/10.1097/AOG.0b013e3182723b1b.
34. Burris HH, Braun JM, Byun HM, Tarantini L, Mercado A, Wright RJ, Schnaas L, Baccarelli AA, Wright RO, Tellez-Rojo MM. Association between birth weight and DNA methylation of IGF2, glucocorticoid receptor and repetitive elements LINE-1 and Alu. Epigenomics 2013; 5:271-81; PMID:23750643; http://dx.doi.org/10.2217/epi.13.24.
35. Capurro H, Konichezky S, Fonseca D, Caldeyro-Barcia R. A simplified method for diagnosis of gestational age in the newborn infant. J Pediatr 1978; 93:120-2; PMID:650322; http://dx.doi.org/10.1016/S0022-3476(78)80621-0.
36. Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, Fell HP, Ferree S, George RD, Grogan T, et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 2008; 26:317-25; PMID:18278033; http://dx.doi.org/10.1038/nbt1385.
37. Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, Biton M, Horwitz E, Prokocimer Z, Prichard M, Hahn G, et al. Host immune system gene targeting by a viral miRNA. Science 2007; 317:376-81; PMID:17641203; http://dx.doi.org/10.1126/science.1140956.
38. Cullen BR. Five questions about viruses and micro- RNAs. PLoS Pathog 2010; 6:e1000787; PMID:20195463; http://dx.doi.org/10.1371/journal.ppat.1000787.
39. Grundhoff A, Sullivan CS. Virus-encoded microRNAs. Virology 2011; 411:325-43; PMID:21277611; http://dx.doi.org/10.1016/j.virol.2011.01.002.
40. Waggott D, Chu K, Yin S, Wouters BG, Liu FF, Boutros PC. NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data. Bioinformatics 2012; 28:1546-8; PMID:22513995; http://dx.doi.org/10.1093/bioinformatics/bts188.
41. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003; 100:9440-5; PMID:12883005; http://dx.doi.org/10.1073/pnas.1530509100.
42. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998; 95:14863-8; PMID:9843981; http://dx.doi.org/10.1073/pnas95.25.14863.